This discovery led to the PML protein being recognised as a tumour suppressor, specifically in acute promyelocytic leukaemia, due to the close association of the PML gene with the retinoic acid receptor-alpha (RAR-α) gene in this disease type [13]. The gene discussed is RARA; the disease is neoplasm.